Esperare participates in Global Health Summit (GHS) 3.0
We are pleased to announce that Dr. Sébastien Mazzuri, Director of Innovation, Research, and Bioethics at EspeRare, took part in the "Precision medicine" panel at the Global Health Summit (GHS) 3.0, held in Basel on December 5. Our board member, Erin Gainer, participated as well.
Organised by the Healthcare Businesswomen’s Association (HBA), the event convened professionals and thought leaders from across the health sector to explore a wide range of timely issues shaping the future of public health, including Diagnostics & Precision Medicine, Reproductive & Mental Health, Policy & Advocacy, and Blueprints for Systems Change.
Dr. Mazzuri contributed EspeRare’s perspective on developing targeted therapies for rare diseases, with a special focus on maternal-fetal health and prenatal interventions. The Summit provided a valuable platform to share our work, engage with new partners, and gain insights that will inform the next chapter of our mission.
To learn more about our projects: ER-004 Programme and Prenatal therapies : the next medical frontier.